Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT01383148. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIB/III Randomized, Double-blind, Placebo Controlled Study Comparing First Line Therapy With or Without TG4010 Immunotherapy Product in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
Study identification
- NCT ID
- NCT01383148
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Transgene
- Industry
- Enrollment
- 222 participants
Conditions and interventions
Conditions
Interventions
- TG4010 Biological
- placebo Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2012
- Primary completion
- Jun 30, 2015
- Completion
- Jun 30, 2016
- Last update posted
- Jan 4, 2017
2012 – 2016
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona | Scottsdale | Arizona | 85259 | — |
| Cotton O'Neil Clinical Research Center | Topeka | Kansas | 66606 | — |
| University of Louisville Hospital | Louisville | Kentucky | 40402 | — |
| Massachusetts General Hospital | Cambridge | Maryland | 2114 | — |
| Oncology/Hematology P.C. | Rockville | Maryland | 20850 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Highlands Oncology Group | Fayetteville | North Carolina | 72703 | — |
| Signal Point Clinical Research Center | Middletown | Ohio | 45042 | — |
| ProMedica Health System Inc | Toledo | Ohio | 43606 | — |
| Abington Hematology Oncology Associates Inc | Willow Grove | Pennsylvania | 19090 | — |
| Texas Oncology, P.A. - Abilene (South) | Abilene | Texas | 79606 | — |
| Mary Crowley Medical Research Center | Dallas | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01383148, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01383148 live on ClinicalTrials.gov.